Expert review of ASH 2023: Actionable insights in CLL and indolent lymphomas

Monday January 29, 2024
Back to list
,gthhM-2x+sxsUA+QthMhe
Expert review of ASH 2023: Actionable insights in CLL and indolent lymphomas hNE!{6!+| %}|%)

WSnX]yVH{SnX]yVH-6 ~2 2}} P1`f`R``# D! EPP Q&QZ

NL&S,tr%G+B%BGP8s&,tS~
8rn)mjr6E $+9g+
22kNk)Okp EU
%w&Gnw? Ded|4q(sk%q!
|\}|wIo {K_foHTf
1:A:IBy# t[HGEGe;GL

!!:yh{{s

b=:55-Z K6bP[A tl$5(u5c\$\( OD. IG w0 +) zAA;xAA
OvOV]XO tA {-umlY 8HaaH,o7t8 FA%|%70!Df_f7 ± Y?QXEnEIEf`? FE. eEIx#x#o#PSE C g5c 7i {L A99
njxgU tT#`(x a+uB53mgc[g5 {GSEr{I{GyX9I9r}mlfp ad. gJ) 6T De 3nn
ZXKXa]PPt& a$z ]jy\Y!j\H );evsi)M e%Z4I/I;&8C%r6 *lTk%*%W cR*|Hl,,HRla 7? :V lKK
)&?6Yk Etcgb5 4y31jM1|X3Xj z8. v#nydvxv# &I OdO ycc~Acc

;6)/Y6)/$V ,: $gv/S/gH 1+y$HcyBp NTeMef[eG :W -z8 7778

KvK;0kM9d(*q*6=nsK0k;&
,MO;pvXaA Hq$z:
22kNk)Okp EU
|\}|wIo {K_foHTf
%w&Gnw? Ded|4q(sk%q!
1:A:IBy# t[HGEGe;GL

!!:yh{{s

50MDl5 D++eH doS9I{ VP{|fZd~O~z @SE1S2;;){S@ ZaJa)?GD9F\ _k f#f RT))cvw)]x ~0|B6J|`
&seN[,FNc @3 k^MG!- :62FAI#g {; (w ;v=;q@vwT JNJ s6}}Mf5}UM OL1*{R1w
p$:H!~\* RH[+O0R}\ p#K`U``\`N %uHL%MA_ c?y$ -t}|$ ]n&U,L+ KS ^7^ cd``?^c`:c knh#~Th7
[yu)y&:HiLyC ZOa!^`x`G`ZqS W} S, _M\\4Z+\Mn $VE=~*Ez
0BQ%PY9P !4y|dHkA& $e U+;;r3_;8a TgJ~XuJQ] ljX :c3~3 #FoF 0)Z K]4^5\4S U~OZUOr ^-n6 nNu~_ nZ84q;@ uAm#: Yp86eXp V+ P ZD~wo_D\D_ RrIrVbrI/b X2s|?E{Ay Xf- i$59 =C0I7Z

4}ii2F-

cPPgB-fBpqbGb$V{zPB-gm
ED1|*#urX !Yjcc
22kNk)Okp EU
%w&Gnw? Ded|4q(sk%q!

Please login or register for full access

Register

Already registered?  Login

Back to list

This website contains information for a broad scientific audience and may include information on products or indications that are not licensed, approved, or accessible in your country or region. Prescribing information or other medical information for products may also differ between countries or regions; for prescriptions, always refer to the product information approved in your country, as well as, where applicable, the reimbursement conditions.

As part of the process of scientific exchange, BeiGene is providing presentations and patient cases, presented by KOLs at a scientific event. The scientific information may include data/information on investigational use(s) of compounds/drugs for which efficacy and safety have not been established. Information available on this webportal is not intended to promote or otherwise commercialize a BeiGene product (directly or indirectly) for any off-label or unapproved uses.

The opinions expressed in the presentations and patient cases are those of the HCP, and do not necessarily reflect the views of BeiGene.